2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association …

BR Haugen, EK Alexander, KC Bible, GM Doherty… - Thyroid, 2016 - liebertpub.com
Background: Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Since the American Thyroid Association's …

A clinical framework to facilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in papillary microcarcinoma

JP Brito, Y Ito, A Miyauchi, RM Tuttle - Thyroid, 2016 - liebertpub.com
Background: The 2015 American Thyroid Association thyroid cancer management
guidelines endorse an active surveillance management approach as an alternative to …

[PDF][PDF] Guidelines for the management of thyroid cancer.

P Perros, K Boelaert, S Colley, C Evans… - Clinical …, 2014 - thyroidcancercanada.org
BTA_Guidelines_for_the_Management_of_Thyroid Cancer_E Page 1 CLINICAL
ENDOCRINOLOGY VOLUME 81 SUPPLEMENT 1 JULY 2014 THE CLINICAL JOURNAL OF …

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association …

DS Cooper, GM Doherty, BR Haugen, RT Kloos… - Thyroid, 2009 - liebertpub.com
Background: Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Since the publication of the American Thyroid …

Treatment with thyroid hormone

B Biondi, L Wartofsky - Endocrine reviews, 2014 - academic.oup.com
Thyroid hormone deficiency can have important repercussions. Treatment with thyroid
hormone in replacement doses is essential in patients with hypothyroidism. In this review …

Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer

B Biondi, DS Cooper - Thyroid, 2010 - liebertpub.com
Background: Despite clinical practice guidelines for the management of differentiated thyroid
cancer (DTC), there are no recommendations on the optimal serum thyrotropin (TSH) …

Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low-and intermediate-risk patients with differentiated thyroid …

LY Wang, AW Smith, FL Palmer, RM Tuttle, A Mahrous… - Thyroid, 2015 - liebertpub.com
Background: Levothyroxine suppression of thyrotropin (TSH) is broadly applied to patients
with thyroid cancer despite lack of consensus on the optimal TSH concentration necessary …

The association between serum TSH concentration and thyroid cancer

K Boelaert - Endocrine-related cancer, 2009 - erc.bioscientifica.com
There is mounting evidence that the serum concentration of TSH is an independent predictor
for the diagnosis of thyroid malignancy in patients with nodular thyroid disease. Furthermore …

Low risk papillary thyroid cancer

JP Brito, ID Hay, JC Morris - Bmj, 2014 - bmj.com
Thyroid cancer is one of the fastest growing diagnoses; more cases of thyroid cancer are
found every year than all leukemias and cancers of the liver, pancreas, and stomach. Most of …

2016 Revised Korean Thyroid Association management guidelines for patients with thyroid nodules and thyroid cancer

KH Yi, EK Lee, HC Kang, SW Kim… - International …, 2016 - synapse.koreamed.org
갑상선결절은 매우 흔한 질환으로, 그 임상적 중요성은 결절의 일부 (7-15%) 가 갑상선암이라는
사실에 근거한다. 2000 년대 들어 고해상도 초음파 기기가 임상에서 널리 쓰이게 되면서 전 …